News

November news includes potential Alzheimer treatments, FDA approval of a device to prevent recurrent stroke, & a newly typified headache disorder.

Oct. news includes an approved deep brain stimulation system for movement disorders & biomarkers that improve risk assessment in atrial fibrillation.

Second-impact syndrome remains a hotly debated diagnosis. A recently published case report evoked 3 commentaries from concussion management experts.

Our Sept. news includes a possible clinical marker and therapy target in Alzheimer disease and MS findings from an optical coherence tomography study.

A study of U.S. Armed Forces asks if severity of traumatic brain injury impacts the likelihood of developing headache or migraine.

Our August news includes a potential classification system for Alzheimer disease, new findings in a 3D model of TBI, and migraine treatments.

Recent neurological studies outline a link between TBI and Parkinson disease, discuss neuroimaging to predict recovery, and warn against DIY tDCS.

Our July news includes the Alzheimer-diabetes link, increased rates of Parkinson, and guidelines for acute migraine treatment in the ED.

An experimental device designed to complement a helmet reduces brain slosh during head impact. Can it also prevent a concussion?

Several points relevant to neurology were discussed during a special session on TBI by the Association for Research in Vision and Ophthalmology.

Our May news includes memory replay disruption in Alzheimer disease, impulse control disorder in Parkinson disease, and return to play in TBI.

Does traumatic brain injury (TBI) inevitably lead to psychiatric disorders? Research presented at AAN 2016 aimed to quantify the risk of psychiatric illness after TBI.

Using advanced and traditional MRIs, researchers measured the amount of white matter brain damage in living retired NFL players.

How important do you consider cognitive rest in the management of TBI? How long do you recommend cognitive rest in patients with mild TBI?

Why do you think sports-related concussion rates have increased – growing popularity of sports, improved awareness, better screening and diagnosis?

While Hollywood adapts reality to create a good story, it’s worth fact-checking this movie’s science to better clarify chronic traumatic encephalopathy.

A neurologist’s main goal is promoting optimal healing after a concussion, but pressure to return athletes to play can make treatment difficult.

How can a clinician best treat a young athlete more concerned with return to play than with his or her health?

New PD medications and treatments are being developed and novel uses for existing drugs are being discovered.

Is fatigue with MS related to diet? Is alcohol intake tied to lower MS disability and severity? Researchers at AAN 2015 reported on how patients are affected by what they eat and drink.

Find the latest developments in epilepsy research on the pages that follow and test your knowledge by answering some of the difficult questions.

Graph theory applied to epilepsy, an abbreviated QOLCE, promising new interventions for neonatal seizures, a minipump to deliver drugs-the latest developments in epilepsy diagnosis and patient care.

Proteins linked in a pathway, drugs that may prevent memory loss, the positive role of sleep, a new memory app-check out these latest new concepts in AD diagnosis and treatment.

Potential approaches to devising strategies that may allow amelioration of this disease are revealed in a recent study. But questions remain.

Worse strokes are more likely to occur in patients who are resistant to aspirin. Better ways to identify those patients are needed.

This new guideline could change the approach many physicians take to treating a first seizure--and could improve patients’ lives.

Deep brain stimulation, stem cell treatment, studying mitochondria-to mark Parkinson’s Awareness Month, we review some noteworthy new concepts.

Advances in neurology science and patient care continue to make news even before the doors to the AAN 2015 Annual Meeting officially open on Saturday. These are the top stories.

The SPG is a promising target for migraine treatment, but robust evidence of efficacy for routine use of noninvasive device–mediated SPG blockade is needed.